AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2014

Nov 12, 2014

32870_dirs_2014-11-12_ef80cfc5-4d24-4249-a675-7dce7ba0b9cc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2014-11-04

Reporting Person: Kramer Robert (EVP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-04	Common Stock	F	1238	$22.31	Disposed	60463	Direct
2014-11-07	Common Stock	S	2625	$24.00	Disposed	57838	Direct

Footnotes

F1: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kramer. Mr. Kramer's direct holdings include restricted stock units as well as shares acquired through private placement.